The Advisory Team at OcuTerra Therapeutics provides strategic guidance and expert insights to support the development and commercialization of OTT166. Comprising experienced professionals in ophthalmology, pharmacology, and business strategy, the team advises on clinical trial design, regulatory pathways, and market entry strategies to ensure the successful treatment of diabetic eye disease.